Contineum Therapeutics, Inc.

10-Q Quarter ended 2026-06-30 Jul 30, 2026 8-K Results of operations (earnings release) Jul 30, 2026 8-K Regulation FD disclosure Jul 13, 2026 8-K Shareholder vote results Jun 26, 2026 10-Q Quarter ended 2026-03-31 May 5, 2026 8-K Results of operations (earnings release) May 5, 2026 8-K Regulation FD disclosure; Other events Apr 30, 2026 10-K Fiscal year ended 2025-12-31 Mar 5, 2026 8-K Results of operations (earnings release); Other events Mar 5, 2026 8-K Director or officer change Jan 26, 2026 8-K Entered a material agreement; Other events Dec 15, 2025 8-K Other events Dec 11, 2025 8-K Other events Nov 20, 2025 10-Q Quarter ended 2025-09-30 Oct 30, 2025 8-K Results of operations (earnings release) Oct 30, 2025 8-K Regulation FD disclosure; Other events Sep 18, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Results of operations (earnings release) Aug 5, 2025 8-K Shareholder vote results Jun 26, 2025 8-K Results of operations (earnings release); Other events May 14, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Other events Apr 28, 2025 8-K Director or officer change Mar 17, 2025 10-K Fiscal year ended 2024-12-31 Mar 6, 2025 8-K Results of operations (earnings release) Mar 6, 2025 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release) Nov 6, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K/A Results of operations (earnings release); Regulation FD disclosure Aug 14, 2024 8-K Results of operations (earnings release) Aug 13, 2024 8-K Director or officer change Jun 24, 2024 8-K Director or officer change May 31, 2024 8-K Director or officer change May 20, 2024 10-Q Quarter ended 2024-03-31 May 16, 2024 8-K Results of operations (earnings release) May 16, 2024 8-K Amended charter or bylaws Apr 9, 2024 4 FORM 4 Aug 3, 2026 144 Aug 3, 2026 144 Aug 3, 2026 SCHEDULE 13G Jul 27, 2026